Author Response to "Insulin Dosing Safety in CKD"

Kidney Int Rep. 2023 Feb 2;8(4):947-948. doi: 10.1016/j.ekir.2023.01.033. eCollection 2023 Apr.

Radica Z Alicic^{1

2}, Joshua J Neumiller^{1

3}, Rodolfo J Galindo^{4

5

6}, Katherine R Tuttle^{1

2

7}

¹ Providence Medical Research Center, Providence Health Care, Spokane, Washington, USA.
² Department of Medicine, University of Washington School of Medicine, Spokane and Seattle, Washington, USA.
³ Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
⁴ University of Miami Miller School of Medicine, Miami, Florida, USA.
⁵ Lennar Medical Center, UMiami Health, Miami, Florida, USA.
⁶ Jackson Memorial Health System, Miami, Florida, USA.
⁷ Nephrology Division, Kidney Research Institute and Institute of Translational Health Sciences, University of Washington, Spokane and Seattle, Washington, USA.

No abstract available